Arizona State Retirement System boosted its holdings in shares of Core Laboratories (NYSE:CLB) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 31,733 shares of the oil and gas company’s stock after purchasing an additional 340 shares during the quarter. Arizona State Retirement System’s holdings in Core Laboratories were worth $1,893,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Eukles Asset Management bought a new stake in shares of Core Laboratories in the 4th quarter worth approximately $27,000. Cornerstone Wealth Management LLC bought a new stake in shares of Core Laboratories in the 3rd quarter worth approximately $122,000. Capital International Inc. CA bought a new stake in shares of Core Laboratories in the 3rd quarter worth approximately $156,000. Quantamental Technologies LLC bought a new stake in shares of Core Laboratories in the 4th quarter worth approximately $179,000. Finally, Parallel Advisors LLC lifted its position in shares of Core Laboratories by 73.3% in the 3rd quarter. Parallel Advisors LLC now owns 1,634 shares of the oil and gas company’s stock worth $189,000 after acquiring an additional 691 shares during the period.
Get Core Laboratories alerts:
CLB has been the subject of a number of research reports. ValuEngine downgraded Core Laboratories from a “buy” rating to a “hold” rating in a research report on Tuesday, October 23rd. Credit Suisse Group reduced their price objective on Core Laboratories from $122.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, October 26th. TheStreet downgraded Core Laboratories from a “b-” rating to a “c+” rating in a research report on Thursday, October 25th. Piper Jaffray Companies reiterated a “hold” rating and issued a $87.00 price objective on shares of Core Laboratories in a research report on Monday, October 29th. Finally, Stifel Nicolaus raised Core Laboratories from a “hold” rating to a “buy” rating and dropped their target price for the stock from $117.00 to $110.00 in a report on Monday, October 29th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $95.09.
Shares of CLB opened at $65.09 on Friday. Core Laboratories has a 1 year low of $56.72 and a 1 year high of $130.34. The company has a quick ratio of 1.81, a current ratio of 2.25 and a debt-to-equity ratio of 1.80. The company has a market capitalization of $2.90 billion, a PE ratio of 28.01, a P/E/G ratio of 2.33 and a beta of 1.87.
Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, January 30th. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.49 by ($0.01). Core Laboratories had a return on equity of 63.86% and a net margin of 11.35%. The company had revenue of $173.20 million during the quarter, compared to analyst estimates of $173.90 million. During the same period in the previous year, the company posted $0.58 earnings per share. The company’s quarterly revenue was up 1.8% on a year-over-year basis. As a group, equities research analysts expect that Core Laboratories will post 2.06 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 15th. Investors of record on Friday, January 25th will be issued a dividend of $0.55 per share. The ex-dividend date of this dividend is Thursday, January 24th. This represents a $2.20 dividend on an annualized basis and a yield of 3.38%.
TRADEMARK VIOLATION NOTICE: “Core Laboratories (CLB) Position Increased by Arizona State Retirement System” was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at www.tickerreport.com/banking-finance/4153048/core-laboratories-clb-position-increased-by-arizona-state-retirement-system.html.
Core Laboratories Profile
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
Recommended Story: How Investors Can Profit from Options Trading
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).